Clinical Trials Directory

Trials / Completed

CompletedNCT03036241

Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis (Dialysis Fistulae)

Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis - a Randomized Prospective Study (Dialysis Fistulae)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
39 (actual)
Sponsor
Helsinki University Central Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether the use of drug-eluting balloons is effective in the treatment of (re)stenosis in dialysis fistulae.

Detailed description

Drug-eluting devices have proved beneficial in the treatment of stenosis in native coronary and lower limb arteries. Stenosis and restenosis is a known problem in dialysis fistulae and drug-eluting devices might be beneficial in this field as well. In the procedure a conventional balloon is passed through the stenosis which is then dilated. After this patients are randomized before a second dilatation with either a conventional balloon or a drug-coated balloon. The stenosis is evaluated preoperatively and followed up by means of ultrasound by a vascular technician. Follow-up will end at 12 months.

Conditions

Interventions

TypeNameDescription
DEVICEConventional angioplastyAngioplasty with conventional balloon
DEVICEAngioplasty with drug-eluting balloonAngioplasty with drug-eluting balloon

Timeline

Start date
2013-01-23
Primary completion
2017-02-28
Completion
2017-02-28
First posted
2017-01-30
Last updated
2017-06-23

Source: ClinicalTrials.gov record NCT03036241. Inclusion in this directory is not an endorsement.